echoloc

Advanced Manufacturing Tech Solutions Tech Stack

GMP manufacturing systems integrator for pharma digitalization

Pharmaceutical Manufacturing Singapore 51–200 employees Founded 2022 Privately Held

Advanced Manufacturing Tech Solutions integrates manufacturing execution systems (MES), automation, and operational technology for regulated pharmaceutical producers. The tech stack reflects a heavily on-premises industrial footprint—SAP, DeltaV, Siemens PCS 7, AVEVA, OSI PI—with active adoption of Azure and AWS signaling a shift toward hybrid cloud for data aggregation. Engineering-heavy hiring (11 of 17 roles) paired with projects spanning MES upgrades, site qualification, and digital strategy suggests the org is scaling implementation capacity while building internal data infrastructure capabilities.

Tech Stack 26 technologies

Core StackSAP Hyper-V VMware Allen-Bradley Power BI DeltaV Emerson DeltaV ISA-88 OPC OSI PI Aveva PI SCADA Modbus Foundation Fieldbus MES DCS PI System Siemens PCS 7 AVEVA InTouch AVEVA System Platform LIMS Microsoft Project Oracle Primavera
AdoptingAWS Azure

What Advanced Manufacturing Tech Solutions Is Building

Challenges

  • Compliance with gmp/gxp standards
  • Optimizing design processes
  • Disaster recovery planning
  • Schedule risks
  • Operational issues
  • Maintaining validated state for critical systems
  • Equipment and facility revalidation
  • Upgrading mes system
  • Troubleshooting mes performance
  • Ensuring gmp compliance

Active Projects

  • Revalidation of equipment and facilities
  • Site startup and expansion projects
  • Developing physical and procedural model designs
  • Implementation of warehouse management systems
  • Equipment, facility, and utility qualification activities
  • Temperature mapping studies
  • Mes system upgrade project
  • Warehouse design activities
  • Digital strategy plan
  • Site-level data infrastructure

Hiring Activity

Accelerating15 roles · 15 in 30d

Department

Engineering
11
Manufacturing
3
HR
2
Finance
1

Seniority

Senior
8
Mid
6
Junior
2
Lead
1
Company intelligence

Find more companies like Advanced Manufacturing Tech Solutions by tech stack, pain points and active projects

Get started free

About Advanced Manufacturing Tech Solutions

Advanced Manufacturing Tech Solutions provides end-to-end GMP manufacturing systems implementation and support for life-science manufacturers. The company helps regulated producers accelerate time-to-market and operational efficiency through Pharma 4.0 digitalization—covering automation, MES deployment, OT networking, and data analytics. Based in Singapore with hiring across Singapore, the US, and India, the firm operates a mix of site services (equipment revalidation, startup support, facility qualification) and system integration projects. Current workstreams include MES system upgrades, warehouse management implementation, temperature mapping studies, and site-level data infrastructure buildout.

HeadquartersSingapore
Company Size51–200 employees
Founded2022
Hiring MarketsSingapore, United States, India

Frequently Asked Questions

What tech stack does Advanced Manufacturing Tech Solutions use?

Core stack includes SAP, DeltaV, Siemens PCS 7, AVEVA (InTouch, System Platform, PI), OSI PI, SCADA, MES, DCS, and LIMS. The firm is actively adopting Azure and AWS for cloud workloads.

What is Advanced Manufacturing Tech Solutions working on?

Current projects include MES system upgrades, equipment and facility revalidation, site startup and expansion, warehouse management system implementation, temperature mapping studies, and digital strategy planning.

How this profile is built

Advanced Manufacturing Tech Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.